Single answer
Is 180 Life Sciences Corp (ATNF) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.78 or -21.71%
(In 20 weeks 12 hours 44 minutes and 21 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
1180 Life Sciences Corp a clinicalstage biotechnology company develops therapeutics for unmet medical needs in chronic pain inflammation fibrosis and other inflammatory diseases Its product development platforms include fibrosis and antitumor necrosis factor antiTNF platform which is under Phase IIb clinical trials that focuses on fibrosis and AntiTNF Synthetic Cannabidiol CBD Analogs platform which is under preclinical trials that are manmade derivatives of CBD and a7nAChR platform an immune suppressive which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor The company was incorporated in 2016 and is headquartered in Palo Alto California
Website: https://180lifesciences.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.49. Cash flow to debt ratio: -0.04. Net profit margin: -5,353.06%. Inflation risk score: high (0.85/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for 180 Life Sciences Corp is $48.6M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for 180 Life Sciences Corp 10 years ago, but if you had invested on 2017-06-27 when the price was $1,444.00, you would have made a loss of $1,441.59 per share or 99.83%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.